Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Radiation Therapy & Diagnostic Imaging Equipment Market by Type (Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Systems, Linear Accelerators, CT Simulators, Others) and by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02619

Pages: NA

Charts: NA

Tables: NA

Radiation therapy utilizes high energy rays to destroy abnormal cells, such as cancer cells, and arrest the growth and division of these cells. Radiations are produced from a machine (external radiation) or from a small container of radioactive material. Diagnostic imaging equipment utilizes electromagnetic radiation to produce images of internal structures of the human body for accurate diagnosis.

The global radiation therapy & diagnostic imaging equipment market is driven by rise in incidence of diseases, such as cancer and other chronic ailments requiring radiation therapy. In addition, rise in demand for oncology information systems (OIS) and sustained increase in healthcare expenditure drive the market growth. However, dearth of medical professionals & systems restrains the market growth. Moreover, advancements in technology, such as automation, and novel radiation therapies, such as plasma radiation therapy and diagnostic imaging equipment, provide opportunities for the market growth.

The global radiation therapy & diagnostic imaging equipment market is segmented based on type, end user, and region. Based on the type, it is classified into computed tomography (CT) scanners, magnetic resonance imaging (MRI) systems, linear accelerators, CT simulators, and others. Based on end user, it is divided into hospitals, clinics and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global radiation therapy & diagnostic imaging equipment market are Varian Medical Systems, Elekta AB, Accuray Incorporated, Nordion, Isoray Medical, Raysearch Laboratories AB, Mevion Medical Systems, C.R. Bard, Mitsubishi Electric Corporation, Theragenics Corporation, P-Cure Ltd., Viewray Inc., Panacea Medical Technologies Pvt. Ltd., and Pronova Solutions, LLC.

Key Benefits

  • The study provides an in-depth analysis of the global radiation therapy & diagnostic imaging equipment market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by type elucidates various forms of radiation therapy and diagnostic imaging equipment available across various regions.
  • Key market players and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

 Key Market Segments

  • By Type
    • Computed Tomography (CT) Scanners
    • Magnetic Resonance Imaging (MRI) Systems
    • Linear Accelerators
    • CT Simulators
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • P-Cure Ltd.
  • Mevion Medical Systems
  • Panacea Medical Technologies Pvt. Ltd.
  • Nordion
  • Isoray Medical
  • Viewray Inc.
  • C.R. Bard
  • Theragenics Corporation
  • Accuray Incorporated
  • Elekta AB
  • Mitsubishi Electric Corporation
  • Raysearch Laboratories AB
  • Varian Medical Systems
  • Pronova Solutions, LLC.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Computed Tomography (CT) Scanners

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Magnetic Resonance Imaging (MRI) Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Linear Accelerators

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. CT Simulators

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Radiation Therapy And Diagnostic Imaging Equipment Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Varian Medical Systems

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Elekta AB

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Accuray Incorporated

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Nordion

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Isoray Medical

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Raysearch Laboratories AB

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Mevion Medical Systems

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. C.R. Bard

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Mitsubishi Electric Corporation

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Theragenics Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

    • 8.11. P-Cure Ltd.

      • 8.11.1. Company Overview

      • 8.11.2. Key Executives

      • 8.11.3. Company Snapshot

      • 8.11.4. Operating Business Segments

      • 8.11.5. Product Portfolio

      • 8.11.6. Business Performance

      • 8.11.7. Key Strategic Moves and Developments

    • 8.12. Viewray Inc.

      • 8.12.1. Company Overview

      • 8.12.2. Key Executives

      • 8.12.3. Company Snapshot

      • 8.12.4. Operating Business Segments

      • 8.12.5. Product Portfolio

      • 8.12.6. Business Performance

      • 8.12.7. Key Strategic Moves and Developments

    • 8.13. Panacea Medical Technologies Pvt. Ltd.

      • 8.13.1. Company Overview

      • 8.13.2. Key Executives

      • 8.13.3. Company Snapshot

      • 8.13.4. Operating Business Segments

      • 8.13.5. Product Portfolio

      • 8.13.6. Business Performance

      • 8.13.7. Key Strategic Moves and Developments

    • 8.14. Pronova Solutions, LLC.

      • 8.14.1. Company Overview

      • 8.14.2. Key Executives

      • 8.14.3. Company Snapshot

      • 8.14.4. Operating Business Segments

      • 8.14.5. Product Portfolio

      • 8.14.6. Business Performance

      • 8.14.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR LINEAR ACCELERATORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR CT SIMULATORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. U.S. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. U.S. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. CANADA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. CANADA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 20. MEXICO RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. FRANCE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. GERMANY RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. ITALY RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. ITALY RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. SPAIN RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. UK RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. UK RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. RUSSIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. REST OF EUROPE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. CHINA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 42. CHINA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. JAPAN RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. INDIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. INDIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. SOUTH KOREA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. AUSTRALIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. THAILAND RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. MALAYSIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. INDONESIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. BRAZIL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH AFRICA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. SAUDI ARABIA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. UAE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. UAE RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. ARGENTINA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 73. REST OF LAMEA RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. VARIAN MEDICAL SYSTEMS: KEY EXECUTIVES
  • TABLE 75. VARIAN MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • TABLE 76. VARIAN MEDICAL SYSTEMS: OPERATING SEGMENTS
  • TABLE 77. VARIAN MEDICAL SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 78. VARIAN MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. ELEKTA AB: KEY EXECUTIVES
  • TABLE 80. ELEKTA AB: COMPANY SNAPSHOT
  • TABLE 81. ELEKTA AB: OPERATING SEGMENTS
  • TABLE 82. ELEKTA AB: PRODUCT PORTFOLIO
  • TABLE 83. ELEKTA AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. ACCURAY INCORPORATED: KEY EXECUTIVES
  • TABLE 85. ACCURAY INCORPORATED: COMPANY SNAPSHOT
  • TABLE 86. ACCURAY INCORPORATED: OPERATING SEGMENTS
  • TABLE 87. ACCURAY INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 88. ACCURAY INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. NORDION: KEY EXECUTIVES
  • TABLE 90. NORDION: COMPANY SNAPSHOT
  • TABLE 91. NORDION: OPERATING SEGMENTS
  • TABLE 92. NORDION: PRODUCT PORTFOLIO
  • TABLE 93. NORDION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. ISORAY MEDICAL: KEY EXECUTIVES
  • TABLE 95. ISORAY MEDICAL: COMPANY SNAPSHOT
  • TABLE 96. ISORAY MEDICAL: OPERATING SEGMENTS
  • TABLE 97. ISORAY MEDICAL: PRODUCT PORTFOLIO
  • TABLE 98. ISORAY MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. RAYSEARCH LABORATORIES AB: KEY EXECUTIVES
  • TABLE 100. RAYSEARCH LABORATORIES AB: COMPANY SNAPSHOT
  • TABLE 101. RAYSEARCH LABORATORIES AB: OPERATING SEGMENTS
  • TABLE 102. RAYSEARCH LABORATORIES AB: PRODUCT PORTFOLIO
  • TABLE 103. RAYSEARCH LABORATORIES AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. MEVION MEDICAL SYSTEMS: KEY EXECUTIVES
  • TABLE 105. MEVION MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • TABLE 106. MEVION MEDICAL SYSTEMS: OPERATING SEGMENTS
  • TABLE 107. MEVION MEDICAL SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 108. MEVION MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. C.R. BARD: KEY EXECUTIVES
  • TABLE 110. C.R. BARD: COMPANY SNAPSHOT
  • TABLE 111. C.R. BARD: OPERATING SEGMENTS
  • TABLE 112. C.R. BARD: PRODUCT PORTFOLIO
  • TABLE 113. C.R. BARD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. MITSUBISHI ELECTRIC CORPORATION: KEY EXECUTIVES
  • TABLE 115. MITSUBISHI ELECTRIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 116. MITSUBISHI ELECTRIC CORPORATION: OPERATING SEGMENTS
  • TABLE 117. MITSUBISHI ELECTRIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 118. MITSUBISHI ELECTRIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. THERAGENICS CORPORATION: KEY EXECUTIVES
  • TABLE 120. THERAGENICS CORPORATION: COMPANY SNAPSHOT
  • TABLE 121. THERAGENICS CORPORATION: OPERATING SEGMENTS
  • TABLE 122. THERAGENICS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 123. THERAGENICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. P-CURE LTD.: KEY EXECUTIVES
  • TABLE 125. P-CURE LTD.: COMPANY SNAPSHOT
  • TABLE 126. P-CURE LTD.: OPERATING SEGMENTS
  • TABLE 127. P-CURE LTD.: PRODUCT PORTFOLIO
  • TABLE 128. P-CURE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. VIEWRAY INC.: KEY EXECUTIVES
  • TABLE 130. VIEWRAY INC.: COMPANY SNAPSHOT
  • TABLE 131. VIEWRAY INC.: OPERATING SEGMENTS
  • TABLE 132. VIEWRAY INC.: PRODUCT PORTFOLIO
  • TABLE 133. VIEWRAY INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: KEY EXECUTIVES
  • TABLE 135. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 136. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: OPERATING SEGMENTS
  • TABLE 137. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 138. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. PRONOVA SOLUTIONS, LLC.: KEY EXECUTIVES
  • TABLE 140. PRONOVA SOLUTIONS, LLC.: COMPANY SNAPSHOT
  • TABLE 141. PRONOVA SOLUTIONS, LLC.: OPERATING SEGMENTS
  • TABLE 142. PRONOVA SOLUTIONS, LLC.: PRODUCT PORTFOLIO
  • TABLE 143. PRONOVA SOLUTIONS, LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET
  • FIGURE 3. SEGMENTATION RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET
  • FIGURE 11. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR LINEAR ACCELERATORS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR CT SIMULATORS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION, BY BY END USER
  • FIGURE 18. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: RADIATION THERAPY AND DIAGNOSTIC IMAGING EQUIPMENT MARKET
  • FIGURE 27. TOP PLAYER POSITIONING, 2024
  • FIGURE 28. VARIAN MEDICAL SYSTEMS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. VARIAN MEDICAL SYSTEMS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. VARIAN MEDICAL SYSTEMS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. ELEKTA AB: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. ELEKTA AB: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. ELEKTA AB: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. ACCURAY INCORPORATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. ACCURAY INCORPORATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. ACCURAY INCORPORATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. NORDION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. NORDION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. NORDION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. ISORAY MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. ISORAY MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. ISORAY MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. RAYSEARCH LABORATORIES AB: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. RAYSEARCH LABORATORIES AB: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. RAYSEARCH LABORATORIES AB: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. MEVION MEDICAL SYSTEMS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. MEVION MEDICAL SYSTEMS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. MEVION MEDICAL SYSTEMS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. C.R. BARD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. C.R. BARD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. C.R. BARD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. MITSUBISHI ELECTRIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. MITSUBISHI ELECTRIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. MITSUBISHI ELECTRIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. THERAGENICS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. THERAGENICS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. THERAGENICS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. P-CURE LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. P-CURE LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. P-CURE LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. VIEWRAY INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. VIEWRAY INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. VIEWRAY INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 64. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 65. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 66. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 67. PRONOVA SOLUTIONS, LLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 68. PRONOVA SOLUTIONS, LLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 69. PRONOVA SOLUTIONS, LLC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Radiation Therapy & Diagnostic Imaging Equipment Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved